Moderna COVID-19 vaccine arriving for Guelph children under 6

The youngest members of the population finally had protection within reach
Health Canada's approval of Moderna's vaccine for infants and toddlers extended vaccination to children six months through five years old.

After more than two years of navigating a pandemic that largely left its youngest members unshielded, Canada has extended the reach of COVID-19 vaccination to children as young as six months. Health Canada's authorization of Moderna's infant and toddler formulation on July 14 opened a door for roughly 1.7 million young Canadians, and by late July the first doses were arriving in Guelph — a quiet but meaningful expansion of a protection that older generations had long taken for granted. The moment asks families to weigh new medical guidance against familiar anxieties, just as another school season draws near.

  • For over two years, children under five remained the last unvaccinated group, leaving parents of infants and toddlers with no approved shield against COVID-19.
  • Health Canada's July 14 authorization broke that barrier, triggering rapid coordination between public health units and local providers to get doses into communities before the school year.
  • Wellington-Dufferin-Guelph Public Health mobilized pharmacies and primary care providers in the same week the shipment arrived, racing to build accessible infrastructure from the ground up.
  • Dosing is carefully calibrated — 25 micrograms per shot, half the amount for older children and a quarter of the adult dose — signaling how deliberately regulators approached this youngest cohort.
  • Families without a family doctor are not left behind: a dedicated phone line offers weekday appointment booking, ensuring access doesn't depend on having an established care relationship.

On July 25, Wellington-Dufferin-Guelph Public Health announced that Moderna's COVID-19 vaccine for children aged six months to five years would arrive in Guelph within days — the first such vaccine authorized for this age group anywhere in Canada. Health Canada had cleared it on July 14, concluding after an independent scientific review that the benefits outweighed the risks for the country's youngest children, a population of roughly 1.7 million.

The rollout would move through two channels: family doctors and pediatricians, or select local pharmacies. The health unit spent the days before the shipment's arrival coordinating with these providers so the infrastructure would be ready when doses landed. Each child in this age group receives two shots four weeks apart, each containing 25 micrograms — half the dose given to children aged six to eleven, and a quarter of what older recipients receive.

Dr. Nicola Mercer, the region's medical officer of health, encouraged parents to speak with their doctor or pharmacist before the fall return to school and daycare. For families without a primary care provider, the health unit established a dedicated phone line — reachable weekdays from 9 a.m. to 4 p.m. at 1-800-265-7293, extension 7006 — as the only way to book through the public health system directly.

The announcement arrived just weeks before classrooms reopened, marking a quiet but significant turning point: after more than two years, the pandemic's youngest and most unprotected group finally had a vaccine of their own.

The youngest children in Guelph are about to gain access to COVID-19 vaccination. Wellington-Dufferin-Guelph Public Health announced on July 25 that the first shipment of Moderna's vaccine for infants and toddlers—children from six months through five years old—would arrive within days. The vaccine had just cleared Health Canada's review process on July 14, making it the first shot of its kind available to this age group across the country.

The arrival marks a significant expansion of Canada's vaccination program. Roughly 1.7 million children nationwide now fall within the eligible age range, and parents in the Guelph area will be able to access the vaccine through two channels: their family doctor or pediatrician, or through select local pharmacies. The health unit spent the week before the shipment's arrival coordinating with these providers to ensure the infrastructure would be in place when doses landed.

Health Canada's authorization came after what the agency described as a thorough independent scientific review. The regulatory body determined that for children in this age bracket, the vaccine's benefits outweighed potential risks. The dosing regimen reflects the younger age of the recipients: each child receives two shots, spaced four weeks apart, with each dose containing 25 micrograms of the vaccine. That's half the amount given to children aged six to eleven, and one quarter of the dose administered to anyone over twelve.

Dr. Nicola Mercer, the medical officer of health and CEO of Wellington-Dufferin-Guelph Public Health, urged parents and caregivers to have conversations with their family doctor or pharmacist about vaccination, particularly as children prepared to return to school and daycare in the fall. She framed vaccination as part of a broader approach to protecting the community from COVID-19, alongside other public health measures.

For families without an established relationship with a primary care provider, the health unit set up a dedicated phone line. Between 9 a.m. and 4 p.m., Monday through Friday, parents could call 1-800-265-7293, extension 7006, to book an appointment. The health unit made clear that telephone booking would be the only way to schedule vaccination appointments for this newly eligible age group through the public health system itself.

The timing placed the vaccine rollout just weeks before the school year, when many parents would be making decisions about their children's health and readiness for the classroom. The announcement reflected a shift in the pandemic response: after more than two years of COVID-19 circulation, vaccination had finally extended to the youngest members of the population.

After a thorough and independent scientific review of the evidence, Health Canada has determined that the benefits of this vaccine for children between 6 months and 5 years of age outweigh the potential risks
— Health Canada
I encourage every parent and caregiver to speak with their primary care provider or pharmacist to answer their vaccination questions—especially for children attending school or daycare this fall
— Dr. Nicola Mercer, medical officer of health and CEO of Wellington-Dufferin-Guelph Public Health
A Conversa do Hearth Outra perspectiva sobre a história
Inventor

Why did it take so long for a vaccine to reach children this young?

Model

The regulatory process for vaccines in young children is deliberately cautious. Infants and toddlers can't tell you how they're feeling, so the safety data has to be especially robust. Health Canada waited for that evidence before moving forward.

Inventor

What's the significance of the dosing being so much smaller?

Model

It's not just about body size. Young immune systems respond differently. A quarter-dose for a toddler versus an adult isn't arbitrary—it's calibrated to trigger protection without overwhelming a developing immune system.

Inventor

Were parents asking for this, or did it come as a surprise?

Model

Both, probably. Some parents had been waiting anxiously for protection for their youngest children. Others were still uncertain about vaccination. The announcement gave everyone a concrete option to discuss with their doctor.

Inventor

Does this change how schools operate in the fall?

Model

Not directly. But it removes one barrier some parents felt—the inability to vaccinate their youngest before sending them into group settings. Whether they choose to use it is still their decision.

Inventor

What happens if someone can't reach their doctor?

Model

That's why the phone line matters. Not every family has a pediatrician or family physician. Public health stepped in to make sure access wasn't limited to people with existing medical relationships.

Quer a matéria completa? Leia o original em Toronto Star ↗
Fale Conosco FAQ